| Dexter Vincent Reneer, MD | |
|
245 Flemingsburg Rd Ste A340, Morehead, KY 40351-1015 | |
| (606) 207-2931 | |
| (606) 783-0964 |
| Full Name | Dexter Vincent Reneer |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology - Maternal & Fetal Medicine |
| Location | 245 Flemingsburg Rd Ste A340, Morehead, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669834867 | NPI | - | NPPES |
| Entity Name | Scotland Memorial Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033103767 PECOS PAC ID: 0648208504 Enrollment ID: O20031105000382 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced that an analysis of the benefits to using a Fractional Flow Reserve-guided intervention strategy found that the technology can improve patient outcomes while saving millions of Euros.
A kill code is embedded in every cell in the body whose function may be to cause the self-destruction of cells that become cancerous, reports a new Northwestern Medicine study. As soon as the cell's inner bodyguards sense it is mutating into cancer, they punch in the kill code to extinguish the mutating cell.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
E-cigarettes spark many concerns, especially when it comes to youth vaping. However, emerging evidence suggests that e-cigarettes can be a helpful tool in smoking cessation.
› Verified 5 days ago
| Entity Name | Unc Physicians Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750704367 PECOS PAC ID: 5496940546 Enrollment ID: O20101115000646 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced that an analysis of the benefits to using a Fractional Flow Reserve-guided intervention strategy found that the technology can improve patient outcomes while saving millions of Euros.
A kill code is embedded in every cell in the body whose function may be to cause the self-destruction of cells that become cancerous, reports a new Northwestern Medicine study. As soon as the cell's inner bodyguards sense it is mutating into cancer, they punch in the kill code to extinguish the mutating cell.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
E-cigarettes spark many concerns, especially when it comes to youth vaping. However, emerging evidence suggests that e-cigarettes can be a helpful tool in smoking cessation.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dexter Vincent Reneer, MD 800 Rose St, Uk Department Of Obstetrics And Gynecology, Lexington, KY 40536-0298 Ph: (859) 218-1661 | Dexter Vincent Reneer, MD 245 Flemingsburg Rd Ste A340, Morehead, KY 40351-1015 Ph: (606) 207-2931 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced that an analysis of the benefits to using a Fractional Flow Reserve-guided intervention strategy found that the technology can improve patient outcomes while saving millions of Euros.
A kill code is embedded in every cell in the body whose function may be to cause the self-destruction of cells that become cancerous, reports a new Northwestern Medicine study. As soon as the cell's inner bodyguards sense it is mutating into cancer, they punch in the kill code to extinguish the mutating cell.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
E-cigarettes spark many concerns, especially when it comes to youth vaping. However, emerging evidence suggests that e-cigarettes can be a helpful tool in smoking cessation.
› Verified 5 days ago
Pamela Tess Smallwood, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 555 W Sun St, Morehead, KY 40351 Phone: 606-207-2931 | |
Stephen Basil Mitchell, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 234 Medical Circle, Morehead, KY 40351 Phone: 606-784-6641 Fax: 606-780-2373 | |
Dr. Frank R Labarbera, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 555 W Sun St, Morehead, KY 40351 Phone: 252-632-0375 | |
Robert H Doepke, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 234 Medical Circle, Morehead, KY 40351 Phone: 606-784-6641 Fax: 606-780-2373 | |
Charles I Smith, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 234 Medical Circle, Morehead, KY 40351 Phone: 606-784-6641 Fax: 606-780-2373 | |
Sharon G. Steele, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 555 W Sun St, Morehead, KY 40351 Phone: 606-207-2931 |